Early treatment of recurrent superficial bladder tumors before endocavitary prophylaxis: local and sistemic safety and tolerability evaluation

被引：0

作者：

Di Cello, V ^{[1
]}

Castigli, M ^{[1
]}

Mondaini, N ^{[1
]}

Maleci, M ^{[1
]}

Gazzarrini, O ^{[1
]}

Dominici, A ^{[1
]}

机构：

[1] Univ Florence, Dept Urol, Florence, Italy

来源：

6TH CONGRESS OF THE MEDITERRANEAN UROLOGICAL ASSOCIATION | 1999年

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

In this study we evaluted local and sistemic safety and tollerability of prophylaxis with Farmorubicina, in 96 patients underwent TUR for solitary recurrent bladder tumor, 0-6 hours since TUR. Our experiencedemostrated no evidence of local or systemic effects during or immediately after treatment. A long term follow-up is necessary to evaluate its efficacy comparing the results obtained in the groups of patients treated with subsequent therapies.

引用

页码：105 / 108

页数：4